Tumor News and Research

RSS

Study shows interferons do not induce the expression of SARS-CoV-2 cell entry receptor

In a new bioRxiv study, authors identified a isoform of ACE2 (designated as deltaACE2 or dACE2) receptor, shown to be induced in various human cell types.

23 Jul 2020

Researchers recreate pancreatic cancer tissue using 3D-cell culture technique

Pancreatic cancer is a life-threatening disease with very poor survival rates in patients, and--despite various efforts--its treatment remains challenging.

23 Jul 2020

Eikonoklastes Therapeutics announces closing of oversubscribed seed financing

Eikonoklastes Therapeutics, a preclinical stage biopharmaceutical company developing next-generation tissue factor (TF) immunotherapies for triple-negative breast cancer (TNBC) and several other diseases with unmet clinical need, today announced closing of an oversubscribed seed financing.

23 Jul 2020

Mysterious enzyme inhibits inflammation in blood vessels, LJI study shows

Scrape your knee, and you'll see some red puffiness appear around the injury. This is inflammation, and it is driven by the immune system.

23 Jul 2020

Research could lead to more efficient cellular immunotherapies for advanced cancers

Adoptive cell transfer immunotherapy is one of the most promising new treatments for people with hard-to-treat cancers.

23 Jul 2020

Study: L-Grb2 has therapeutic efficacy in preclinical models of ovarian and uterine cancer

The cover for issue 29 of Oncotarget features, "In vivo effects of treatment with L-Grb2 in combination with anti-angiogenic therapy in an ovarian tumor model," by Lara, et al. which reported that adaptor proteins such as growth factor receptor-bound protein-2 play important roles in cancer cell signaling.

23 Jul 2020

Study identifies common characteristics of pediatric vestibular schwannomas

Vestibular schwannomas, more commonly known as acoustic neuromas, are benign brain tumors that develop on the balance (vestibular) and hearing or auditory nerves leading from the inner ear to the brain.

23 Jul 2020

Ashion Analytics and Elevation Oncology form innovative cancer treatment partnership

Ashion Analytics LLC today announced a partnership with Elevation Oncology, a clinical stage biopharmaceutical company, focused on the matching of patients with tumors harboring an NRG1 gene fusion identified using Ashion's proprietary GEM ExTra test with CRESTONE, a registration-directed Phase 2 study sponsored by Elevation Oncology.

23 Jul 2020

Study finds viable drug target for triple negative breast cancer

One member of a larger family of oxygen sensing enzymes could offer a viable target for triple negative breast cancer (TNBC), UTSW researchers report in a new study.

23 Jul 2020

Vesigen Therapeutics to develop and commercialize novel drug-delivery technologies

Harvard University's Office of Technology Development (OTD) and the Harvard T.H. Chan School of Public Health today announced the launch of Vesigen Therapeutics, a startup company that aims to overcome the challenge of delivering next-generation therapeutics, such as gene-editing complexes, RNA molecules, and other large proteins, to intracellular targets in specific tissues of interest.

23 Jul 2020

New approach tracks tumors in real time, could improve outcomes for cancer patients

A team of University of Alberta researchers has developed a faster way of tracking the movement of tumours in the body during radiation therapy, which could significantly improve outcomes for cancer patients.

23 Jul 2020

New method can detect cancer cells in the abdominal cavity in real time

A research team from Tel Aviv University's Zimin Institute for Engineering Solutions Advancing Better Lives, led by Prof. Noam Shomron and doctoral student Artem Danilevsky, has developed a method to detect cancer cells in the abdominal cavity in real time.

22 Jul 2020

Tumor News and Research

Study shows interferons do not induce the expression of SARS-CoV-2 cell entry receptor

Researchers recreate pancreatic cancer tissue using 3D-cell culture technique

Eikonoklastes Therapeutics announces closing of oversubscribed seed financing

Mysterious enzyme inhibits inflammation in blood vessels, LJI study shows

Research could lead to more efficient cellular immunotherapies for advanced cancers

Study: L-Grb2 has therapeutic efficacy in preclinical models of ovarian and uterine cancer

Study identifies common characteristics of pediatric vestibular schwannomas

Ashion Analytics and Elevation Oncology form innovative cancer treatment partnership

Study finds viable drug target for triple negative breast cancer

Vesigen Therapeutics to develop and commercialize novel drug-delivery technologies

New approach tracks tumors in real time, could improve outcomes for cancer patients

New method can detect cancer cells in the abdominal cavity in real time

Experts use genomic analysis tools to create personalized treatment for kidney cancer patients

Immunotherapeutic intervention to reduce stress prevents tumor metastases

New method of communication relies on ‘mechano-chemical’ signals to control cell movement

Study suggests new ways to fight aggressive brain cancer

Scientists identify cellular mechanism that shows promise in treating cancer

Researchers identify potential new combination therapy to treat head and neck cancer

Silver-plated gold nanostars could be used to identify early biomarkers of cancer

Proximity of mutated cells guides the initiation of tumor

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News